Company: EVGN
Filing Date: 2025-03-27
Form Type: 20-F
Source: 0001178913-25-001092
Chunk: 15

Company: Evogene Ltd.
Filing Date: 2025-03-27
Form: 20-F
Item: Item 3
Chunk 15
---
  Directors                                                                                           
  Mr. Nir Nimrodi (3)(4)                  56      Chairperson of the Board                            
  Ms. Sarit Firon (3)(4)                  58      Director                                            
  Mr. Dan Falk (1)(2)(4)                  79      Director                                            
  Dr. Adrian Percy (4)                    59      Director                                            
  Mr. Leon Y. Recanati (1)(2)(3)(4)       76      Director                                            
  Dr. Oded Shoseyov (1)(2)(4)             68      Director                                            

____________________________

  (1)      Member of our Audit Committee.  

  (2)      Member of our Compensation and Nominating Committee.  

  (3)      Member of our Pricing/Investment Committee.  

  (4)      Independent director under the Nasdaq Listing Rules.  

79

Executive Officers

Mr. Ofer Havivhas
served as Evogene's President and Chief Executive Officer since December 2004 after having joined the company in January 2002 as Chief
Financial Officer. Mr. Haviv serves as Chairperson of the Board of Directors of our subsidiaries. Mr. Haviv served as a director
of the company from 2006 to 2007, and from March 2025. Mr. Haviv is a Certified Public Accountant and holds a BA in Accounting
and Economics from Tel-Aviv University, Israel.

Mr. Yaron Eldadhas
served as Chief Financial Officer of Evogene since April 2022. Mr. Eldad has held various chief financial officer positions over the last
25 years in public and private technology and biotechnology companies, including Yamba Group Int. Ltd. from 2011 to 2021, Recoly NV from
2008 to 2010, and e-Sim Ltd. from 1998 to 2007. Mr. Eldad also serves on the board of directors and as chairman of the audit and compensation
committees of B. O. S. Better Online Solutions Ltd. Mr. Eldad holds a B. A. in Economics and Accounting from the Ben-Gurion University of
the Negev, Israel, an Executive MBA in Strategic Management from the Hebrew University of Jerusalem, Israel, and an M. A. in law from the
Bar-Ilan University, Israel.

Dr. Gabi Tarcicwas appointed as Evogene’s Vice President Product in September